Reports of Unexpected Late Side Effects of Accelerated Partial Breast Irradiation-Radiobiological Considerations

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 4, 2010, Pages 969-973

  Bentzen, Søren M ^a   Yarnold, John R ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BRACHYTHERAPY; BREAST; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; EDITORIAL; FIBROSIS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; IRRADIATION; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIOBIOLOGY; SKIN DISEASE; SKIN TELANGIECTASIA; TELANGIECTASIA; TREATMENT OUTCOME;

BREAST; DOSE FRACTIONATION; FEMALE; FIBROSIS; HUMANS; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; SKIN; TIME FACTORS;

EID: 77953575218     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.01.059     Document Type: Editorial

References (29)

1. Chen PY, Wallace M, Mitchell C, et al. Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. In press
2. Hepel J.T., Tokita M., Macausland S.G., et al. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 75 (2009) 1290-1296
3. Jagsi R., Ben-David M.A., Moran J.M., et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 76 (2010) 71-78
4. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet Oncol 9 (2008) 331-341
5. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet 371 (2008) 1098-1107
6. Owen J.R., Ashton A., Bliss J.M., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial. Lancet Oncol 7 (2006) 467-471
7. Yarnold J., Ashton A., Bliss J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial. Radiother Oncol 75 (2005) 9-17
8. Whelan T., MacKenzie R., Julian J., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94 (2002) 1143-1150
9. Marcial V.A., Pajak T.F., Chang C., et al. Hyperfractionated photon irradiation in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: Preliminary report by the Radiation Therapy Oncology Group (RTOG). Int J Radiat Oncol Biol Phys 13 (1985) 41-47
10. Cox J.D., Pajak T.F., Marcial V.A., et al. ASTRO plenary: Interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: Results from Radiation Therapy Oncology Group 8313. Int J Radiat Oncol Biol Phys 20 (1991) 1191-1195
11. Bentzen S.M., Ruifrok A.C.C., and Thames H.D. Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: Clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy. Radiother Oncol 38 (1996) 89-101
12. Guttenberger R., Thames H.D., and Ang K.K. Is the experience with CHART compatible with experimental data? A new model of repair kinetics and computer simulations. Radiother Oncol 25 (1992) 280-286
13. Turesson I., and Notter G. Accelerated versus conventional fractionation. The degree of incomplete-repair in human skin with a four-hour-fraction interval studied after postmastectomy irradiation. Acta Oncol 27 (1988) 169-179
14. Nyman J., and Turesson I. Does the interval between fractions matter in the range 4-8 h in radiotherapy? A study of acute and late human skin reactions. Radiother Oncol 34 (1995) 171-178
15. Turesson I., and Thames H.D. Repair capacity and kinetics of human skin during fractionated radiotherapy: Erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up. Radiother Oncol 15 (1989) 169-188
16. Bentzen S.M., Saunders M.I., and Dische S. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. Radiother Oncol 53 (1999) 219-226
17. Bentzen S.M. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nat Rev Cancer 6 (2006) 702-713
18. Bentzen S.M., Thames H.D., and Overgaard M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother Oncol 15 (1989) 267-274
19. Brunt A.M., Sydenham M., Bliss J., et al. A 5-fraction regimen of adjuvant radiotherapy for women with early breast cancer: first analysis of the randomised UK FAST trial (ISRCTN62488883, CRUKE/04/015). EJC Supplements 7 (2009) 2
20. Bentzen S.M., Overgaard M., Thames H.D., et al. Early and late normal-tissue injury after postmastectomy radiotherapy alone or combined with chemotherapy. Int J Radiat Biol 56 (1989) 711-715
21. Bentzen S.M., Skoczylas J.Z., Overgaard M., and Overgaard J. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst 88 (1996) 918-922
22. Collette S., Collette L., Budiharto T., et al. Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: A study based on the EORTC Trial 22881-10882 "boost versus no boost". Eur J Cancer 44 (2008) 2587-2599
23. Borger J.H., Kemperman H., Smitt H.S., et al. Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys 30 (1994) 1073-1081
24. Polgar C., Fodor J., Major T., et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma-5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 69 (2007) 694-702
25. Wazer D.E., Kaufman S., Cuttino L., et al. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 64 (2006) 489-495
26. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25 (2007) 3259-3265
27. Al Uwini S., Antonini N., Poortmans P.M., et al. The influence of the use of CT-planning on the irradiated boost volume in breast conserving treatment. Radiother Oncol 93 (2009) 87-93
28. Smith B.D., Arthur D.W., Buchholz T.A., et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74 (2009) 987-1001
29. Sauer R., Sautter-Bihl M.L., Budach W., et al. Accelerated partial breast irradiation: Consensus statement of 3 German Oncology societies. Cancer 110 (2007) 1187-1194